Table 2.
Clinical description of analyzed population.
| Parameter | Patients Group (n = 220) |
Control Group (n = 223) |
|---|---|---|
| Gender, male (%) | 59% | 48% |
| Age, years (mean ± SD) | 11.45 ± 3.56 | 12.14 ± 3.31 |
| Asthma severity | - | |
| Mild, n (%) | 29 (13.2) | - |
| Moderate, n (%) | 121 (55.0) | - |
| Severe, n (%) | 70 (31.8) | - |
| Positive SPT (%) | 68.2 | - |
| FEV1/FVC pred (mean ± SD) | 88.5 ± 12.5 | 104.35 ± 8.18 |
| FEV1% pred (mean ± SD) | 85.3 ± 15.1 | 106.15 ± 12.1 |
| FVC% pred (mean ± SD) | 89.9 ± 15.1 | 100.5 ± 10.9 |
| PEF% pred (mean ± SD) | 81.3 ± 15.8 | 90.3 ± 12.9 |
| FeNO (ppb) (mean ± SD) | 28.6 ± 34.3 | 16.6 ± 14.4 |
| IgE (IU/mL) (mean ± SD) | 257.5 ± 326.7 | - |
FEV1—forced expiratory volume in the first second, FVC—forced vital capacity, PEF—peak expiratory flow, FeNO—fraction of exhaled NO.